HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher Traenka Selected Research

Aspirin (Acetylsalicylic Acid)

5/2024Antithrombotic Treatment for Cervical Artery Dissection: A Systematic Review and Individual Patient Data Meta-Analysis.
2/2024Toward Individual Treatment in Cervical Artery Dissection: Subgroup Analysis of the TREAT-CAD Randomized Trial.
1/2021Cervical and intracranial artery dissections.
1/2021Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial.
9/2020Biomarkers and antithrombotic treatment in cervical artery dissection - Design of the TREAT-CAD randomised trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christopher Traenka Research Topics

Disease

22Stroke (Strokes)
05/2024 - 05/2015
16Ischemic Stroke
02/2024 - 09/2015
8Blood Vessel Dissection
05/2024 - 06/2017
7Hemorrhage
05/2024 - 09/2015
6Cerebral Hemorrhage
01/2023 - 05/2017
6Atrial Fibrillation
09/2022 - 01/2016
3Hematoma
01/2023 - 05/2017
3Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2021 - 11/2016
2Ischemia
02/2024 - 09/2020
1Transient Ischemic Attack
01/2022
1Infarction (Infarctions)
09/2020
1Type 2 Diabetes Mellitus (MODY)
01/2020
1Hypercholesterolemia
01/2020
1Hemorrhagic Stroke
01/2017
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
05/2015
1Pathologic Constriction (Stenosis)
05/2015
1Neoplasms (Cancer)
10/2010
1Medulloblastoma
10/2010

Drug/Important Bio-Agent (IBA)

19AnticoagulantsIBA
05/2024 - 09/2015
12Vitamin KFDA Link
01/2023 - 09/2015
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2024 - 09/2020
4N(4)-oleylcytosine arabinosideIBA
01/2023 - 09/2015
3RivaroxabanIBA
01/2018 - 01/2017
2Biomarkers (Surrogate Marker)IBA
05/2024 - 09/2020
2Glucose (Dextrose)FDA LinkGeneric
11/2019 - 05/2015
1Levodopa (L Dopa)FDA LinkGeneric
01/2024
1Antifibrinolytic Agents (Antifibrinolytics)IBA
01/2023
1Tranexamic Acid (AMCA)FDA Link
01/2023
1Hemostatics (Antihemorrhagics)IBA
01/2023
1AcenocoumarolIBA
01/2021
1Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2021
1Phenprocoumon (Liquamar)FDA Link
01/2021
1Warfarin (Coumadin)FDA LinkGeneric
01/2021
1Extracellular Matrix ProteinsIBA
10/2020
1Retinaldehyde (Retinal)IBA
09/2020
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
09/2020
1Metformin (Glucophage)FDA LinkGeneric
01/2020
1Antihypertensive Agents (Antihypertensives)IBA
01/2020
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
12/2017
1Transforming Growth Factor-beta Type II ReceptorIBA
06/2017
1NucleotidesIBA
06/2017
1Factor Xa (Coagulation Factor Xa)IBA
01/2017
12,6-dinitrotoluene (DNT)IBA
01/2017
1Small Interfering RNA (siRNA)IBA
10/2010
1Messenger RNA (mRNA)IBA
10/2010
1Proteins (Proteins, Gene)FDA Link
10/2010

Therapy/Procedure

8Therapeutics
02/2024 - 09/2015
2Secondary Prevention
02/2020 - 11/2016
1Treatment Delay
02/2024
1Stroke Rehabilitation
01/2024
1Contraindications
11/2019
1Endarterectomy (Thromboendarterectomy)
06/2019
1Aftercare (After-Treatment)
01/2017